PALI

PALISADE BIO INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

PALISADE BIO INC (PALI) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$17.41M; the largest are Steven Cohen, Renaissance Technologies, Ken Griffin. This quarter: 2 added, 2 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Mixed

Common-stock holders4

Congress trades0

Price$1.45vs quarter-end-30.62%

Sectors0

This quarter's moves

New0

Added2

Trimmed / sold2

Top holder

Steven Cohen

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Investor	Period	Value	Shares	% of portfolio	Action

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.